1,3-dimethylurate (BioDeep_00000017743)

 

Secondary id: BioDeep_00000398321, BioDeep_00000405467, BioDeep_00000593092

human metabolite PANOMIX_OTCML-2023 Endogenous blood metabolite


代谢物信息卡片


1,3-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

化学式: C7H8N4O3 (196.0596378)
中文名称: 1,3-二甲基尿酸
谱图信息: 最多检出来源 Homo sapiens(blood) 0.06%

Reviewed

Last reviewed on 2024-09-13.

Cite this Page

1,3-dimethylurate. BioDeep Database v3. PANOMIX ltd, a top metabolomics service provider from China. https://query.biodeep.cn/s/1,3-dimethylurate (retrieved 2024-09-17) (BioDeep RN: BioDeep_00000017743). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

分子结构信息

SMILES: Cn1c(=O)c2nc(O)[nH]c2n(C)c1=O
InChI: InChI=1S/C7H8N4O3/c1-10-4-3(8-6(13)9-4)5(12)11(2)7(10)14/h1-2H3,(H2,8,9,13)

描述信息

1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152, 4039734) [HMDB]
1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID:11712316, 15833286, 3506820, 15013152, 4039734).
1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi.

同义名列表

6 个代谢物同义名

1,3-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione; 1,3-Dimethyluric acid; 1,3-Dimethylic acid; 1,3-Dimethylurate; 1,3-Dimethylate; Oxytheophylline



数据库引用编号

12 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(1)

PlantCyc(0)

代谢反应

1 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(1)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Yuko Kuroda, Kazuaki Taguchi, Yuki Enoki, Kazuaki Matsumoto, Seiji Hori, Junko Kizu. Age-Associated Theophylline Metabolic Activity Corresponds to the Ratio of 1,3-Dimethyluric Acid to Theophylline in Mice. Biological & pharmaceutical bulletin. 2019; 42(8):1423-1427. doi: 10.1248/bpb.b19-00232. [PMID: 31366878]
  • Michael E Rybak, Maya R Sternberg, Ching-I Pao, Namanjeet Ahluwalia, Christine M Pfeiffer. Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake. The Journal of nutrition. 2015 Apr; 145(4):766-74. doi: 10.3945/jn.114.205476. [PMID: 25833779]
  • Ying Liu, Yan Zhan, Yi-Fan Zhang, Xiao-Yan Chen, Da-Fang Zhong. [Quantitative analysis of theophylline and its metabolites in urine of Chinese healthy subjects after oral administration of theophylline sustained-release tablets]. Yao xue xue bao = Acta pharmaceutica Sinica. 2014 Jul; 49(7):1039-43. doi: . [PMID: 25233637]
  • Jung-woo Chae, Dong-hyun Kim, Byung-yo Lee, Eun jung Kim, Kwang-il Kwon. Development and validation of a sensitive LC-MS/MS method for the simultaneous quantitation of theophylline and its metabolites in rat plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2012 Mar; 889-890(?):44-9. doi: 10.1016/j.jchromb.2012.01.028. [PMID: 22365533]
  • Eun Jin Kim, Joseph Kwon, Seong Hwa Park, Chiyoul Park, Young-Bae Seo, Hyun-Kyoo Shin, Ho Kyoung Kim, Kwang-Sik Lee, Sang-Yun Choi, Do Hyun Ryu, Geum-Sook Hwang. Metabolite profiling of Angelica gigas from different geographical origins using 1H NMR and UPLC-MS analyses. Journal of agricultural and food chemistry. 2011 Aug; 59(16):8806-15. doi: 10.1021/jf2016286. [PMID: 21774558]
  • Karin Ardjomand-Woelkart, Manfred Kollroser, Li Li, Hartmut Derendorf, Veronika Butterweck, Rudolf Bauer. Development and validation of a LC-MS/MS method based on a new 96-well Hybrid-SPE™-precipitation technique for quantification of CYP450 substrates/metabolites in rat plasma. Analytical and bioanalytical chemistry. 2011 Jun; 400(8):2371-81. doi: 10.1007/s00216-010-4618-3. [PMID: 21225250]
  • Yuko Watanabe, Naohiko Chohnabayashi, Hideki Nasu, Naoki Nishimura, Noboru Uchiyama, Junko Kizu. Usefulness of the simultaneous determination of serum levels of theophylline and its metabolites in patients medicated with theophylline preparation. Biomedical chromatography : BMC. 2011 Apr; 25(4):432-4. doi: 10.1002/bmc.1473. [PMID: 20586107]
  • Kyung H Yang, Young S Jung, Dae Y Lee, Joo H Lee, Young C Kim, Myung G Lee. Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats: return of the parameters in 96-hour KPLPS rats to the control levels. Drug metabolism and disposition: the biological fate of chemicals. 2008 May; 36(5):811-5. doi: 10.1124/dmd.107.018499. [PMID: 18308837]
  • Yasuyo Suda, Kazuhiko Hanada, Shin-Ichi Tsuchiwata, Makoto Saito, Tomoo Nakamura, Yuji Ito, Yoichi Ishikawa, Kenji Kushida, Hiroyasu Ogata. [Population pharmacokinetic analysis of two theophylline formulations in premature neonates and infants with apnea]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2008 Apr; 128(4):635-40. doi: 10.1248/yakushi.128.635. [PMID: 18379181]
  • Hye D Choi, Hee E Kang, Hye J Chung, Soo K Bae, Karen N Shin, Myung G Lee. Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats. Biopharmaceutics & drug disposition. 2007 Nov; 28(8):445-54. doi: 10.1002/bdd.573. [PMID: 17847127]
  • Masayuki Nadai, Miki Kato, Kazumasa Yasui, Masao Kimura, Ying Lan Zhao, Jun Ueyama, Yoshimi Tsunekawa, Hideo Yoshizumi, Takaaki Hasegawa. Lack of effect of aciclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats. Biological & pharmaceutical bulletin. 2007 Mar; 30(3):562-8. doi: 10.1248/bpb.30.562. [PMID: 17329857]
  • Yeomin Yoon, Hyung-Doo Park, Kyoung Un Park, Jin Q Kim, Yoon-Seok Chang, Junghan Song. Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios. European journal of clinical pharmacology. 2006 Aug; 62(8):627-31. doi: 10.1007/s00228-006-0165-4. [PMID: 16841220]
  • Hiroyuki Nosaka, Masayuki Nadai, Miki Kato, Kazumasa Yasui, Hideo Yoshizumi, Mika Miyoshi, Ying Lan Zhao, Kenji Baba, Kenzo Takagi, Takaaki Hasegawa. Effect of a newly developed ketolide antibiotic, telithromycin, on metabolism of theophylline and expression of cytochrome P450 in rats. Life sciences. 2006 May; 79(1):50-6. doi: 10.1016/j.lfs.2005.12.022. [PMID: 16423372]
  • Rocco Orlando, Roberto Padrini, Mauro Perazzi, Sara De Martin, Pierpaolo Piccoli, Pietro Palatini. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine. Clinical pharmacology and therapeutics. 2006 May; 79(5):489-99. doi: 10.1016/j.clpt.2006.01.012. [PMID: 16678550]
  • Sandrine Derkenne, Christine P Curran, Howard G Shertzer, Timothy P Dalton, Nadine Dragin, Daniel W Nebert. Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice. Pharmacogenetics and genomics. 2005 Jul; 15(7):503-11. doi: 10.1097/01.fpc.0000167326.00411.50. [PMID: 15970798]
  • Makiko Kizawa, Etsuko Miyamoto, Shuka Aono, Junichi Kawakami, Isao Adachi. Inhibition of theophylline metabolism by suplatast and its metabolites in rats. Biological & pharmaceutical bulletin. 2005 Jun; 28(6):1061-5. doi: 10.1248/bpb.28.1061. [PMID: 15930745]
  • Junghan Song, Kyoung Un Park, Hyung Doo Park, Yeomin Yoon, Jin Q Kim. High-throughput liquid chromatography-tandem mass spectrometry assay for plasma theophylline and its metabolites. Clinical chemistry. 2004 Nov; 50(11):2176-9. doi: 10.1373/clinchem.2004.035337. [PMID: 15502093]
  • Mirosława Zydroń, Jacek Baranowski, Irena Baranowska. Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples. Journal of separation science. 2004 Oct; 27(14):1166-72. doi: 10.1002/jssc.200401841. [PMID: 15537072]
  • Eun Jung Kim, Ok Kyung Suh, Myung Gull Lee. Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats. Life sciences. 2003 Jan; 72(11):1231-45. doi: 10.1016/s0024-3205(02)02373-1. [PMID: 12570924]
  • Su Yeon Yu, Hye Chin Chung, Eun Jung Kim, So Hee Kim, Inchull Lee, Sang Geon Kim, Myung Gull Lee. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation. The Journal of pharmacy and pharmacology. 2002 Dec; 54(12):1687-92. doi: 10.1211/002235702333. [PMID: 12542900]
  • K M Koch, B M Ricci, N S Hedayetullah, D Jewell, K E Kersey. Effect of alosetron on theophylline pharmacokinetics. British journal of clinical pharmacology. 2001 Nov; 52(5):596-600. doi: 10.1046/j.0306-5251.2001.01477.x. [PMID: 11736869]
  • K A Georgia, V F Samanidou, I N Papadoyannis. Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin. Journal of chromatography. B, Biomedical sciences and applications. 2001 Aug; 759(2):209-18. doi: 10.1016/s0378-4347(01)00251-1. [PMID: 11499474]
  • Y C Bechtel, H Lelouët, S Hrusovsky, M P Brientini, G Mantion, G Paintaud, J P Miguet, P R Bechtel. Caffeine metabolism before and after liver transplantation. International journal of clinical pharmacology and therapeutics. 2001 Feb; 39(2):53-60. doi: 10.5414/cpp39053. [PMID: 11270802]
  • S Dadashzadeh, H Tajerzaden. Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways. European journal of drug metabolism and pharmacokinetics. 2001 Jan; 26(1-2):77-83. doi: 10.1007/bf03190380. [PMID: 11554438]
  • S C Yuan, C J Wang, H W Kuo, M C Maa, Y S Hsieh. Effect of tea and coffee consumption on serum uric acid levels by liquid-chromatographic and uricase methods. Bulletin of environmental contamination and toxicology. 2000 Sep; 65(3):300-6. doi: 10.1007/s0012800128. [PMID: 10903352]
  • E J Park, G Ko, J Kim, D H Sohn. Biotransformation of theophylline in cirrhotic rats induced by biliary obstruction. Archives of pharmacal research. 1999 Feb; 22(1):60-7. doi: 10.1007/bf02976437. [PMID: 10071961]
  • T Tateishi, M Asoh, A Yamaguchi, T Yoda, Y J Okano, Y Koitabashi, S Kobayashi. Developmental changes in urinary elimination of theophylline and its metabolites in pediatric patients. Pediatric research. 1999 Jan; 45(1):66-70. doi: 10.1203/00006450-199901000-00011. [PMID: 9890610]
  • W L Macias, R F Bergstrom, B J Cerimele, K Kassahun, D E Tatum, J T Callaghan. Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men. Pharmacotherapy. 1998 Nov; 18(6):1237-48. doi: . [PMID: 9855322]
  • W Cao, H T Zhuo, G Chen, S S Ling. Pharmacokinetics of theophylline metabolites in 8 Chinese patients. Zhongguo yao li xue bao = Acta pharmacologica Sinica. 1998 Sep; 19(5):437-9. doi: . [PMID: 10375804]
  • N Rodopoulos, A Norman. Elimination of theophylline metabolites in healthy adults. Scandinavian journal of clinical and laboratory investigation. 1997 May; 57(3):233-40. doi: 10.3109/00365519709060032. [PMID: 9238759]
  • H J Kuh, C K Shim. Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats. Archives of pharmacal research. 1994 Apr; 17(2):124-30. doi: 10.1007/bf02974236. [PMID: 10319144]
  • H Konishi, K Morita, A Yamaji. Effect of fluconazole on theophylline disposition in humans. European journal of clinical pharmacology. 1994; 46(4):309-12. doi: 10.1007/bf00194397. [PMID: 7957514]
  • L Fraisse, J B Verlhac, B Roche, M C Rascle, A Rabion, J L Seris. Long-chain-substituted uric acid and 5,6-diaminouracil derivatives as novel agents against free radical processes: synthesis and in vitro activity. Journal of medicinal chemistry. 1993 May; 36(10):1465-73. doi: 10.1021/jm00062a020. [PMID: 8496914]
  • T Ogiso, M Iwaki, T Tanino, K Okuyama, S Uno. Effect of mexiletine on elimination and metabolic conversion of theophylline and its major metabolites in rats. Biological & pharmaceutical bulletin. 1993 Feb; 16(2):163-7. doi: 10.1248/bpb.16.163. [PMID: 8364452]
  • T E Leakey, A C Elias-Jones, P E Coates, K J Smith. Pharmacokinetics of theophylline and its metabolites during acute renal failure. A case report. Clinical pharmacokinetics. 1991 Nov; 21(5):400-8. doi: 10.2165/00003088-199121050-00007. [PMID: 1773552]
  • A Hurwitz, J L Vacek, G W Botteron, M I Sztern, E M Hughes, A Jayaraj. Mexiletine effects on theophylline disposition. Clinical pharmacology and therapeutics. 1991 Sep; 50(3):299-307. doi: 10.1038/clpt.1991.140. [PMID: 1914365]
  • M Nadai, T Hasegawa, T Kuzuya, I Muraoka, K Takagi, H Yoshizumi. Effects of enoxacin on renal and metabolic clearance of theophylline in rats. Antimicrobial agents and chemotherapy. 1990 Sep; 34(9):1739-43. doi: 10.1128/aac.34.9.1739. [PMID: 2285287]
  • M Sarkar, R E Polk, P S Guzelian, C Hunt, H T Karnes. In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes. Antimicrobial agents and chemotherapy. 1990 Apr; 34(4):594-9. doi: 10.1128/aac.34.4.594. [PMID: 2344166]
  • G J Wijnands, T B Vree, T J Janssen, P J Guelen. Drug-drug interactions affecting fluoroquinolones. The American journal of medicine. 1989 Dec; 87(6C):47S-51S. doi: NULL. [PMID: 2603893]
  • Y Kasuya, T Furuta, H Shimota. Capillary gas chromatographic-mass spectrometric determination of stable isotopically labelled and unlabelled theophylline in serum and urine and of 1,3-dimethyluric acid in urine. Journal of chromatography. 1989 Sep; 494(?):101-8. doi: 10.1016/s0378-4347(00)82660-2. [PMID: 2584310]
  • N Brion, E Naline, D Beaumont, M Pays, C Advenier. Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects. British journal of clinical pharmacology. 1989 Mar; 27(3):391-5. doi: 10.1111/j.1365-2125.1989.tb05383.x. [PMID: 2497767]
  • I Kishimoto, Y Tanigawara, K Okumura, R Hori. Blood oxygen tension-related change of theophylline clearance in experimental hypoxemia. The Journal of pharmacology and experimental therapeutics. 1989 Mar; 248(3):1237-42. doi: NULL. [PMID: 2703972]
  • I Bonnacker, D Berdel, R Süverkrüp, A von Berg. Renal clearance of theophylline and its major metabolites: age and urine flow dependency in paediatric patients. European journal of clinical pharmacology. 1989; 36(2):145-50. doi: 10.1007/bf00609186. [PMID: 2721539]
  • T B Vree, M Martea, R G Tiggeler, Y A Hekster, J C Hafkenscheid. Pharmacokinetics of theophylline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetics. 1988 Dec; 15(6):390-5. doi: 10.2165/00003088-198815060-00003. [PMID: 3243042]
  • S G Shin, D Juan, M Rammohan. Theophylline pharmacokinetics in normal elderly subjects. Clinical pharmacology and therapeutics. 1988 Nov; 44(5):522-30. doi: 10.1038/clpt.1988.189. [PMID: 3180633]
  • M C Rogge, W R Solomon, A J Sedman, P G Welling, R D Toothaker, J G Wagner. The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline disposition. Clinical pharmacology and therapeutics. 1988 Nov; 44(5):579-87. doi: 10.1038/clpt.1988.197. [PMID: 3180639]
  • D C Knoppert, M Spino, R Beck, J J Thiessen, S M MacLeod. Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease. Clinical pharmacology and therapeutics. 1988 Sep; 44(3):254-64. doi: 10.1038/clpt.1988.147. [PMID: 3046811]
  • C Saunier, P du Souich, D Hartemann, A Sautegeau. Theophylline disposition during acute and chronic hypoxia in the conscious dog. Research communications in chemical pathology and pharmacology. 1987 Sep; 57(3):291-9. doi: . [PMID: 3671881]
  • S Bompadre, P Ercolani, L Leone. [Determination of theophylline in the plasma by rapid solid-phase extraction]. Bollettino della Societa italiana di biologia sperimentale. 1987 Aug; 63(8):717-23. doi: NULL. [PMID: 3663373]
  • J Beckmann, W Elsässer, U Gundert-Remy, R Hertrampf. Enoxacin--a potent inhibitor of theophylline metabolism. European journal of clinical pharmacology. 1987; 33(3):227-30. doi: 10.1007/bf00637553. [PMID: 3480222]
  • S G Gilbert, Y So, R D Klassen, S Geoffroy, B Stavric, D C Rice. Elimination of chronically consumed caffeine in the pregnant monkey (Macaca fascicularis). The Journal of pharmacology and experimental therapeutics. 1986 Dec; 239(3):891-7. doi: NULL. [PMID: 3795047]
  • U Gundert-Remy, B Krüdewagen, R Hildebrandt. Plasma concentrations of theophylline and its metabolites in a theophylline intoxicated child--reevaluation of published Km-values. British journal of clinical pharmacology. 1986 Nov; 22(5):617-8. doi: 10.1111/j.1365-2125.1986.tb02945.x. [PMID: 3790410]
  • I M Ramzan, G Levy. Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats. The Journal of pharmacology and experimental therapeutics. 1986 Mar; 236(3):708-13. doi: . [PMID: 3485196]
  • D Berdel, G Heimann. [Peculiarities of the pharmacokinetics and pharmacodynamics of theophylline in children]. Wiener klinische Wochenschrift. 1984 Aug; 96(16):616-21. doi: . [PMID: 6516414]
  • R Hildebrandt, U Gundert-Remy, H Möller, E Weber. Lack of clinically important interaction between erythromycin and theophylline. European journal of clinical pharmacology. 1984; 26(4):485-9. doi: 10.1007/bf00542146. [PMID: 6734707]
  • K E Opheim, V Ainardi, V A Raisys. Increase in apparent theophylline concentration in the serum of two patients as measured by some immunoassay methods (caused by 1,3-dimethyluric acid?). Clinical chemistry. 1983 Sep; 29(9):1698-9. doi: 10.1093/clinchem/29.9.1698. [PMID: 6349858]
  • D J Birkett, J O Miners, J Attwood. Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid. British journal of clinical pharmacology. 1983 Jan; 15(1):117-9. doi: 10.1111/j.1365-2125.1983.tb01475.x. [PMID: 6849735]
  • D D Tang-Liu, R L Williams, S Riegelman. Nonlinear theophylline elimination. Clinical pharmacology and therapeutics. 1982 Mar; 31(3):358-69. doi: 10.1038/clpt.1982.46. [PMID: 7060318]
  • J J Grygiel, D J Birkett. Cigarette smoking and theophylline clearance and metabolism. Clinical pharmacology and therapeutics. 1981 Oct; 30(4):491-6. doi: 10.1038/clpt.1981.193. [PMID: 7285483]
  • J H Jonkman, D Tang, R A Upton, S Riegelman. Measurement of excretion characteristics of theophylline and its major metabolites. European journal of clinical pharmacology. 1981; 20(6):435-41. doi: 10.1007/bf00542096. [PMID: 7286053]
  • . . . . doi: . [PMID: 14977550]